AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial 22 Jun 2020
The ICR responds to decision by NICE not to recommend pembrolizumab as first-line treatment for advanced head and neck cancer 15 Jan 2020
Major trial backs immunotherapy as standard first-line treatment for head and neck cancer 23 Nov 2019